REGN846
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for REGN846, covering 2013-10-28 to 2013-10-28. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis [Phase 1, Phase 2]